CA Stock MarketDetailed Quotes

AQS Aequus Pharmaceuticals Inc

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayTrading Jul 26 12:23 ET
3.32MMarket Cap-1666P/E (TTM)

Aequus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-43.03%52.56K
-81.53%254.9K
-86.72%50.88K
-96.16%13.36K
-69.48%92.25K
-49.17%1.38M
-55.42%383.08K
-51.14%347.92K
-46.82%346.49K
-38.54%302.28K
Operating revenue
-43.03%52.56K
-81.53%254.9K
-86.72%50.88K
-96.16%13.36K
-69.48%92.25K
-49.17%1.38M
-55.42%383.08K
-51.14%347.92K
-46.82%346.49K
-38.54%302.28K
Cost of revenue
-54.88%17.59K
7.41%111.23K
-72.91%15.3K
-57.52%10.46K
298.64%38.99K
142.08%103.56K
129.04%56.5K
133.38%24.62K
155.81%12.66K
274.32%9.78K
Gross profit
-34.35%34.96K
-88.74%143.66K
-89.11%35.57K
-99.10%2.9K
-81.79%53.26K
-52.24%1.28M
-60.87%326.58K
-53.91%323.3K
-48.37%333.83K
-40.21%292.5K
Operating expense
-15.97%645.5K
-21.47%2.96M
-6.72%700.97K
-8.70%774.83K
-30.10%768.16K
-6.56%3.77M
-28.56%751.51K
-12.38%848.69K
4.21%1.08M
11.33%1.1M
Selling and administrative expenses
15.11%612.42K
-27.37%2.52M
-17.45%667.05K
-17.88%665.98K
-35.21%532.06K
-3.84%3.48M
-17.39%808.07K
-7.95%810.97K
16.58%1.04M
-5.29%821.23K
-Selling and marketing expense
88.37%89.91K
-27.41%359.24K
-0.12%165.44K
-37.69%71.24K
-89.30%47.73K
43.21%494.89K
-1.25%165.64K
85.07%114.32K
139.41%150.45K
14.48%445.95K
-General and administrative expense
7.89%522.52K
-27.36%2.17M
-21.92%501.61K
-14.63%594.75K
29.06%484.33K
-8.81%2.98M
-20.73%642.43K
-14.96%696.66K
7.23%884.98K
-21.42%375.28K
Research and development costs
--0
78.57%301.28K
--0
1,126.54%74.1K
-18.18%201.36K
-43.16%168.71K
-271.02%-91.38K
-87.70%6.04K
-92.53%7.95K
179.99%246.11K
Depreciation amortization depletion
-4.79%33.08K
6.42%138.16K
-2.57%33.92K
9.71%34.75K
9.71%34.75K
1.34%129.83K
70.65%34.81K
-17.73%31.67K
-14.50%31.67K
-1.53%31.67K
-Depreciation and amortization
-4.79%33.08K
6.42%138.16K
-2.57%33.92K
9.71%34.75K
9.71%34.75K
1.34%129.83K
70.65%34.81K
-17.73%31.67K
-14.50%31.67K
-1.53%31.67K
Operating profit
14.60%-610.54K
-12.90%-2.82M
-56.59%-665.4K
-46.93%-771.93K
11.36%-714.9K
-82.68%-2.5M
-95.53%-424.93K
-96.66%-525.38K
-92.52%-741.21K
-61.96%-806.51K
Net non-operating interest income (expenses)
-77.48%-51.65K
25.49%-141.05K
-54.91%-44.66K
-375.49%-35.04K
72.77%-29.1K
57.14%-189.3K
73.10%-28.83K
93.68%-7.37K
50.64%-46.22K
13.99%-106.88K
Non-operating interest income
77.06%687
-83.26%4.14K
6.26%2.99K
-92.41%743
-92.51%388
87.41%24.71K
-47.76%2.81K
150.73%9.79K
177.36%6.93K
269.79%5.18K
Non-operating interest expense
77.47%52.34K
-32.16%145.18K
50.59%47.64K
108.58%35.78K
-73.68%29.49K
-52.95%214.01K
-71.89%31.64K
-85.76%17.16K
-44.71%53.16K
-10.83%112.06K
Other net income (expenses)
132.18%102
99.35%-3.39K
98.97%-5.82K
-89.74%3.31K
90.93%-317
-108,345.64%-522.71K
-19,649.86%-566.82K
1,366.65%32.28K
4,019.69%15.33K
-704.67%-3.5K
Gain on sale of security
132.18%102
-107.69%-3.39K
-8,847.69%-5.82K
-89.74%3.31K
90.93%-317
9,238.59%44.05K
97.74%-65
1,366.65%32.28K
4,019.69%15.33K
-704.67%-3.5K
Special income (charges)
----
--0
----
----
----
---566.76K
----
----
----
----
-Less:Write off
----
--0
----
----
----
--566.76K
----
----
----
----
Income before tax
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
-31.17%-500.47K
-61.18%-772.11K
-47.49%-916.89K
Income tax
Earnings from equity interest net of tax
Net income
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
-31.17%-500.47K
-61.18%-772.11K
-47.49%-916.89K
Net income continuous operations
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
-31.17%-500.47K
-61.18%-772.11K
-47.49%-916.89K
Noncontrolling interests
Net income attributable to the company
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
-31.17%-500.47K
-61.18%-772.11K
-47.49%-916.89K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
11.05%-662.09K
7.64%-2.96M
29.86%-715.87K
-60.58%-803.65K
18.82%-744.32K
-77.39%-3.21M
-211.76%-1.02M
-31.17%-500.47K
-61.18%-772.11K
-47.49%-916.89K
Diluted earnings per share
50.08%-0.005
0.00%-0.02
0
-165.04%-0.01
0.00%-0.01
-100.00%-0.02
0
-31.14%-0.0038
-176.85%-0.01
0.00%-0.01
Basic earnings per share
50.08%-0.005
0.00%-0.02
0
-165.04%-0.01
0.00%-0.01
-100.00%-0.02
0
-31.14%-0.0038
-176.85%-0.01
0.00%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -43.03%52.56K-81.53%254.9K-86.72%50.88K-96.16%13.36K-69.48%92.25K-49.17%1.38M-55.42%383.08K-51.14%347.92K-46.82%346.49K-38.54%302.28K
Operating revenue -43.03%52.56K-81.53%254.9K-86.72%50.88K-96.16%13.36K-69.48%92.25K-49.17%1.38M-55.42%383.08K-51.14%347.92K-46.82%346.49K-38.54%302.28K
Cost of revenue -54.88%17.59K7.41%111.23K-72.91%15.3K-57.52%10.46K298.64%38.99K142.08%103.56K129.04%56.5K133.38%24.62K155.81%12.66K274.32%9.78K
Gross profit -34.35%34.96K-88.74%143.66K-89.11%35.57K-99.10%2.9K-81.79%53.26K-52.24%1.28M-60.87%326.58K-53.91%323.3K-48.37%333.83K-40.21%292.5K
Operating expense -15.97%645.5K-21.47%2.96M-6.72%700.97K-8.70%774.83K-30.10%768.16K-6.56%3.77M-28.56%751.51K-12.38%848.69K4.21%1.08M11.33%1.1M
Selling and administrative expenses 15.11%612.42K-27.37%2.52M-17.45%667.05K-17.88%665.98K-35.21%532.06K-3.84%3.48M-17.39%808.07K-7.95%810.97K16.58%1.04M-5.29%821.23K
-Selling and marketing expense 88.37%89.91K-27.41%359.24K-0.12%165.44K-37.69%71.24K-89.30%47.73K43.21%494.89K-1.25%165.64K85.07%114.32K139.41%150.45K14.48%445.95K
-General and administrative expense 7.89%522.52K-27.36%2.17M-21.92%501.61K-14.63%594.75K29.06%484.33K-8.81%2.98M-20.73%642.43K-14.96%696.66K7.23%884.98K-21.42%375.28K
Research and development costs --078.57%301.28K--01,126.54%74.1K-18.18%201.36K-43.16%168.71K-271.02%-91.38K-87.70%6.04K-92.53%7.95K179.99%246.11K
Depreciation amortization depletion -4.79%33.08K6.42%138.16K-2.57%33.92K9.71%34.75K9.71%34.75K1.34%129.83K70.65%34.81K-17.73%31.67K-14.50%31.67K-1.53%31.67K
-Depreciation and amortization -4.79%33.08K6.42%138.16K-2.57%33.92K9.71%34.75K9.71%34.75K1.34%129.83K70.65%34.81K-17.73%31.67K-14.50%31.67K-1.53%31.67K
Operating profit 14.60%-610.54K-12.90%-2.82M-56.59%-665.4K-46.93%-771.93K11.36%-714.9K-82.68%-2.5M-95.53%-424.93K-96.66%-525.38K-92.52%-741.21K-61.96%-806.51K
Net non-operating interest income (expenses) -77.48%-51.65K25.49%-141.05K-54.91%-44.66K-375.49%-35.04K72.77%-29.1K57.14%-189.3K73.10%-28.83K93.68%-7.37K50.64%-46.22K13.99%-106.88K
Non-operating interest income 77.06%687-83.26%4.14K6.26%2.99K-92.41%743-92.51%38887.41%24.71K-47.76%2.81K150.73%9.79K177.36%6.93K269.79%5.18K
Non-operating interest expense 77.47%52.34K-32.16%145.18K50.59%47.64K108.58%35.78K-73.68%29.49K-52.95%214.01K-71.89%31.64K-85.76%17.16K-44.71%53.16K-10.83%112.06K
Other net income (expenses) 132.18%10299.35%-3.39K98.97%-5.82K-89.74%3.31K90.93%-317-108,345.64%-522.71K-19,649.86%-566.82K1,366.65%32.28K4,019.69%15.33K-704.67%-3.5K
Gain on sale of security 132.18%102-107.69%-3.39K-8,847.69%-5.82K-89.74%3.31K90.93%-3179,238.59%44.05K97.74%-651,366.65%32.28K4,019.69%15.33K-704.67%-3.5K
Special income (charges) ------0---------------566.76K----------------
-Less:Write off ------0--------------566.76K----------------
Income before tax 11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M-31.17%-500.47K-61.18%-772.11K-47.49%-916.89K
Income tax
Earnings from equity interest net of tax
Net income 11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M-31.17%-500.47K-61.18%-772.11K-47.49%-916.89K
Net income continuous operations 11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M-31.17%-500.47K-61.18%-772.11K-47.49%-916.89K
Noncontrolling interests
Net income attributable to the company 11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M-31.17%-500.47K-61.18%-772.11K-47.49%-916.89K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 11.05%-662.09K7.64%-2.96M29.86%-715.87K-60.58%-803.65K18.82%-744.32K-77.39%-3.21M-211.76%-1.02M-31.17%-500.47K-61.18%-772.11K-47.49%-916.89K
Diluted earnings per share 50.08%-0.0050.00%-0.020-165.04%-0.010.00%-0.01-100.00%-0.020-31.14%-0.0038-176.85%-0.010.00%-0.01
Basic earnings per share 50.08%-0.0050.00%-0.020-165.04%-0.010.00%-0.01-100.00%-0.020-31.14%-0.0038-176.85%-0.010.00%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg